Abstract

Background: Intestinal epithelial cells (IECs) can produce cytokines and chemokines that play an important role in the mucosal immune response. Regulation of this production is important to prevent inflammatory tissue damage. The root and stem barks of Acanthopanax species have been used as a tonic and sedative as well as in the treatment of rheumatism and diabetes. The aim of this study was to examine the inhibitory effect of acanthoic acid isolated from Acanthopanax koreanum (Araliaceae), on IL-8 production via mitogen-activated protein kinases (MAPKs) and nuclear factor-kappa B (NF-κB) in TNF-α-stimulated human colon epithelial cells. Methods: HT29 cells were stimulated with TNF-α in the presence or absence of acanthoic acid. IL-8 production was measured by enzyme-linked immunosorbent assay (ELISA) and reverse transcription-PCR (RT-PCR). MAPK activation and IκB/NF-κB expression were assessed by Western blot analysis. NF-κB activation was determined using immunofluorescence localization and electrophoretic mobility shift assay (EMSA). Results: Acanthoic acid suppressed TNF-α-induced IL-8 production in a dose-dependent manner. Furthermore, acanthoic acid inhibited TNF-α-induced MAPKs (p38, JNK1/2, and ERK1/2) activation, IκB degradation, NF-κB nuclear translocation, and NF-κB/DNA binding activity. Conclusion: Acanthoic acid might inhibit TNF-α-mediated IL-8 production by blocking in both the MAPKs and NF-κB pathways in HT29 cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.